Elevance Health (Elevance) reported third quarter 2022 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings, and adjusted earnings per share
Blue Cross Blue Shield Plans mid-2022 financial results continue to improve as the pandemic recedes into the past
A key strength of HCSC continues to be the Blue Cross and Blue Shield brand and license under which it markets its products in Illinois, Texas, New Mexico, Montana, and Oklahoma which has helped the company to command a top market position in each of these states
Blue Cross Blue Shield Plans should experience moderate increase of demand for care with the pandemic receding which should have a positive effect on profitability
Amazon Pharmacy is partnering with Blue Plans in five states and Prime Therapeutics (Prime) to address the affordability of prescription medications
Rite Aid is implementing a number of strategies to make up Q3 2021 PBM revenue shortfall, including closing 63 stores and improving PBM margins from its new rebate aggregation agreement with Prime Therapeutics
Evio will work to improve medication affordability and patients’ clinical outcomes and medication experiences. The five plans in total provide coverage to more than 20 million members across the United States.
Civica supplies its more than 50-member health systems with 20 generic drugs